Arteris (NASDAQ:AIP) VP Paul L. Alpern Sells 2,278 Shares

Key Points

• Paul Alpern, VP of Arteris, sold 2,278 shares of the company's stock for a total of $19,795.82, reducing his ownership by 3.00% to 73,587 shares valued at approximately $639,471.03.
• Arteris' stock traded down $0.06 to $8.66 with a market capitalization of $369.35 million, and it has a 52-week range of $5.46 to $14.29.
• Analyst ratings for AIP stock are mixed, with TD Cowen raising the price target to $15.00 and Wall Street Zen downgrading it to a "sell," while the consensus remains a "buy" with three analysts supporting this view.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul L. Alpern sold 2,278 shares of the firm's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $8.69, for a total value of $19,795.82. Following the completion of the sale, the vice president directly owned 73,587 shares of the company's stock, valued at approximately $639,471.03. This represents a 3.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Arteris Price Performance

NASDAQ AIP traded up $0.18 during trading on Monday, hitting $8.93. The company's stock had a trading volume of 393,742 shares, compared to its average volume of 510,660. The business's 50 day simple moving average is $9.47 and its 200-day simple moving average is $8.20. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The business had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts expect that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st. TD Cowen lifted their target price on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a report on Monday. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Arteris has an average rating of "Buy" and a consensus target price of $15.00.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Raymond James Financial Inc. purchased a new position in Arteris during the second quarter valued at approximately $32,000. CWM LLC increased its position in shares of Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after buying an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris in the first quarter valued at approximately $95,000. Savant Capital LLC purchased a new stake in shares of Arteris in the second quarter valued at approximately $97,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of Arteris in the second quarter worth approximately $104,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.